Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma
- 1 December 2017
- journal article
- Published by Elsevier in Research in Veterinary Science
- Vol. 115, 484-489
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Overexpression of Tyro3 and its implications on hepatocellular carcinoma progressionInternational Journal of Oncology, 2015
- Ror2 as a Therapeutic Target in CancerPharmacology & Therapeutics, 2015
- MET and ALK as Targets for the Treatment of NSCLCCurrent Pharmaceutical Design, 2014
- Dynamic and Nuclear Expression of PDGFRα and IGF-1R in Alveolar RhabdomyosarcomaMolecular Cancer Research, 2013
- Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated doseBMC Veterinary Research, 2013
- Expression of PDGFR‐β and Kit in canine anal sac apocrine gland adenocarcinoma using tissue immunohistochemistryVeterinary and Comparative Oncology, 2011
- PROGNOSTIC SIGNIFICANCE OF TUMOR HISTOLOGY AND COMPUTED TOMOGRAPHIC STAGING FOR RADIATION TREATMENT RESPONSE OF CANINE NASAL TUMORSVeterinary Radiology & Ultrasound, 2009
- Angiogenesis as a therapeutic targetNature, 2005
- Assessing epidermal growth factor receptor expression in tumours: What is the value of current test methods?European Journal of Cancer, 2005
- ErbB-targeted therapeutic approaches in human cancerExperimental Cell Research, 2003